JNJ Press releases
News
Partner news
GRAIL Announces $300 Million Raised in Oversubscribed Series C Financing
Read full storyJNJ Press releases
Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen
Read full storyIn the media
Europe’s piece of the pie where European Life Science innovators can take the lead with Jeanne Bolger
Read full storyPartner news
BRIEF-Provention Bio Files For IPO Of Up To $50 Million
Read full storyPartner news
Provention Bio Announces Agreements with MacroGenics for Two Clinical-Stage Assets for the Treatment of Autoimmune Disorders
Read full storyJNJ Press releases
Janssen to Acquire BeneVir Biopharm to Advance Immunotherapy Regimen
Read full storyIn the media
Belgium chosen for first J&J ‘JLABS’ incubator in Europe
Read full storyPartner news